All In Biotech

Drug Trial Radar · NCT01340482

A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia

A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia

Last checked: Nov 20, 2026Latest source record: Jun 18, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

29

Actual

Start

Apr 2011

Primary completion

May 2013

Study completion Oct 2013

Sponsor

Lead sponsor
Kyowa Kirin Co., Ltd.Industry
Sponsor type
Industry
First posted
Apr 22, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to assess the safety and efficacy of repeated subcutaneous (SC) injections of KRN23 in adult subjects with X-Linked Hypophosphatemia (XLH). A Bone Substudy will evaluate the effects of single-blind KRN23 versus Placebo on bone mineral density and bone quality.

Conditions

  • X-linked Hypophosphatemia

Interventions

  • KRN23Drug

    Subjects will receive escalating doses of KRN23 administered by SC injections every 28-days (up to 4 doses) based on a dosing algorithm and discretion of the investigator and sponsor.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and Efficacy of Repeated SC Injections of KRN23Time frame: On-Treatment: 6.5 months, 27 total visits

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California, San Francisco Medical Center

    San Francisco, California

  • Yale University School of Medicine

    New Haven, Connecticut

  • Clinical Research Center, Indiana University School of Medicine

    Indianapolis, Indiana

  • Duke Clinical Research Unit

    Durham, North Carolina

  • University of Texas Health Science Center at Houston

    Houston, Texas

  • Shriners Hospital for Children - Canada

    Montreal, Quebec, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.